P. Østergaard
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Biotechnology top 5%
- Microbial Metabolism and Applications
Papers in ⓘ
-
- Blood Coagulation and Thrombosis Mechanisms 6
-
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- Keith S. Wilson (3 shared papers)G.J. Davies (3 shared papers)Ulla Hedner (9 shared papers)A.M. Brzozowski (3 shared papers)Klas Norrby (2 shared papers)Palle Schneider (2 shared papers)David Bergqvist (6 shared papers)Debbie Yaver (2 shared papers)
- Journals
- Thrombosis Research (6 papers)Biochemical Journal (3 papers)Thrombosis and Haemostasis (3 papers)Blood Coagulation & Fibrinolysis (1 paper)Diabetic Medicine (1 paper)
- Partner nations
- DenmarkSwedenUnited Kingdom
In The Last Decade
P. Østergaard
30 papers receiving 985 citations
Peers
Comparison fields: 5 of 94
- Internal Medicine 264
- Biotechnology 148
- Hematology 159
- Cell Biology 198
- Cardiology and Cardiovascular Medicine 240
Countries citing papers authored by P. Østergaard
This map shows the geographic impact of P. Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Østergaard more than expected).
Fields of papers citing papers by P. Østergaard
This network shows the impact of papers produced by P. Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Østergaard. The network helps show where P. Østergaard may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Østergaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 274 | |
| 2 | 2001 | 62 | |
| 3 | 2003 | 60 | |
| 4 | 1994 | 60 | |
| 5 | 1996 | 57 | |
| 6 | 1985 | 49 | |
| 7 | 1989 | 39 | |
| 8 | Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin. | 1994 | 36 |
| 9 | 1998 | 34 | |
| 10 | 1991 | 30 | |
| 11 | 1991 | 27 | |
| 12 | 1993 | 27 | |
| 13 | 1993 | 25 | |
| 14 | 1992 | 24 | |
| 15 | 1993 | 24 | |
| 16 | 1986 | 23 | |
| 17 | 1991 | 22 | |
| 18 | 1997 | 21 | |
| 19 | 1995 | 21 | |
| 20 | 1987 | 18 |
About P. Østergaard
P. Østergaard is a scholar working on Hematology, Molecular Biology, Cardiology and Cardiovascular Medicine, Internal Medicine and Cell Biology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (8 papers), Proteoglycans and glycosaminoglycans research (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Enzyme-mediated dye degradation (3 papers). The work is most often cited by research in Internal Medicine (264 citations), Biotechnology (148 citations), Hematology (159 citations), Cell Biology (198 citations) and Cardiology and Cardiovascular Medicine (240 citations). P. Østergaard has collaborated with scholars based in Denmark, Sweden and United Kingdom. Frequent co-authors include Keith S. Wilson, G.J. Davies, Ulla Hedner, A.M. Brzozowski, Klas Norrby, Palle Schneider, David Bergqvist, Debbie Yaver, Stephen H.M. Brown and Anders H. Pedersen. Their work appears in journals such as Thrombosis Research, Biochemical Journal, Thrombosis and Haemostasis, Blood Coagulation & Fibrinolysis and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.